Lucent BioSciences
Seed Round in 2021
Lucent Biosciences specializes in the development of innovative biofertilizers aimed at enhancing agricultural sustainability. The company offers a unique class of micronutrient fertilizers that promote higher crop yields and nutrient levels while being environmentally friendly. Their products are designed to improve soil health and sequester carbon, contributing to climate-positive farming practices. By utilizing sustainable bioactive crop nutrition, Lucent Biosciences enables farmers to cultivate nutrient-dense crops without polluting groundwater, thereby supporting regenerative agriculture and reducing overall costs per hectare.
Arbutus Medical
Seed Round in 2020
Arbutus Medical Inc., founded in 2014 and headquartered in Vancouver, Canada, specializes in the development and manufacturing of surgical power tools aimed at enhancing surgical efficiency and accessibility. The company offers a range of products, including its flagship orthopedic power tool system, which features innovative solutions such as the HEX and PRO drill kits, as well as sterile-packed orthopedic procedure kits. These tools are designed to meet the needs of various healthcare settings, including trauma centers, veterinary hospitals, military deployments, and hospitals in over 30 low- and middle-income countries. Arbutus Medical focuses on "frugal innovation," aiming to reduce healthcare costs and improve access to orthopedic surgery for millions of patients by 2030.
Lucent BioSciences
Seed Round in 2020
Lucent Biosciences specializes in the development of innovative biofertilizers aimed at enhancing agricultural sustainability. The company offers a unique class of micronutrient fertilizers that promote higher crop yields and nutrient levels while being environmentally friendly. Their products are designed to improve soil health and sequester carbon, contributing to climate-positive farming practices. By utilizing sustainable bioactive crop nutrition, Lucent Biosciences enables farmers to cultivate nutrient-dense crops without polluting groundwater, thereby supporting regenerative agriculture and reducing overall costs per hectare.
Alpha9 Theranostics
Seed Round in 2020
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets. Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.
Starling Minds
Seed Round in 2019
Starling Minds Inc. is a Vancouver-based company founded in 2013 that specializes in digital mental health therapy. It offers an online Cognitive Behavioral Therapy program designed to address stress, burnout, anxiety, and depression in workplace settings. The company provides comprehensive solutions for various sectors, including business, disability management, education, healthcare, insurance, and workers' compensation. By utilizing an artificial intelligence-powered platform, Starling Minds licenses its technology to insurance payers, healthcare providers, and employers in a business-to-business model. This approach aims to alleviate the chronic shortage of affordable mental health professionals by offering effective support for employees, facilitating their return to work, and promoting overall workplace productivity and mental well-being.
Mesentech
Seed Round in 2019
Mesentech Inc. is a regenerative medicine company based in Vancouver, Canada, specializing in the development of therapeutics that target bone-related diseases. The company utilizes a unique prodrug platform that delivers bi-specific small-molecule therapeutics selectively to bone tissue, minimizing side effects associated with systemic exposure. Its lead product, MES1007, is a bone-targeted prodrug of a prostaglandin mimetic, designed to potentially reverse bone loss linked to conditions such as Duchenne muscular dystrophy and osteoporosis. Mesentech's proprietary technology overcomes the challenges of delivering medications to the difficult-to-treat bone environment, which often requires high drug doses and can lead to significant side effects. Through pre-clinical in-vivo models, the effectiveness of this bone-targeting system has been confirmed, positioning Mesentech to address various low-bone-density disorders and enhance bone healing outcomes. The company was incorporated in 2013 and continues to innovate in the field of bone therapeutics.
Penny AI Technologies Inc. is a Canadian company that specializes in developing an artificial intelligence-driven customer relationship management (CRM) application tailored for direct sales. Founded in 2017 and based in Squamish, the platform helps sellers efficiently manage their daily activities, organize content, and enhance customer experiences. By utilizing an automation engine, Penny prioritizes next steps and generates targeted lists of income-producing activities, enabling sales consultants and businesses to focus their efforts strategically. The platform leverages data, machine learning, and algorithms to streamline customer orders, prospects, and promotional lists, ultimately empowering users to run their businesses more effectively and increase revenue.
Keycafe
Seed Round in 2019
Keycafe Inc. is a company that offers an online platform for remotely managing access to homes and rental properties, catering primarily to homeowners in Canada. Established in November 2012 and based in Vancouver, Keycafe utilizes software as a service (SaaS) and Internet of Things (IoT) technology to facilitate intelligent property access management. The company's solutions enable users to securely exchange keys, making it easier for property owners and renters to manage access efficiently and conveniently.
ThisFish
Seed Round in 2018
ThisFish is a leader in seafood traceability and production software, focused on enhancing profits and sustainability within the seafood industry. The company offers innovative solutions that streamline data entry and reporting processes, enabling workers to efficiently utilize wireless devices. This technology not only saves management time but also equips executives with high-quality data to make informed decisions. By promoting transparency and accountability in the seafood supply chain, ThisFish aims to foster social, environmental, and financial sustainability. Founded by Ecotrust Canada, a Vancouver-based non-profit, ThisFish is committed to ensuring that consumers can reward responsible seafood harvesting and handling practices, thus improving productivity and compliance in seafood operations globally.
Starling Minds
Seed Round in 2018
Starling Minds Inc. is a Vancouver-based company founded in 2013 that specializes in digital mental health therapy. It offers an online Cognitive Behavioral Therapy program designed to address stress, burnout, anxiety, and depression in workplace settings. The company provides comprehensive solutions for various sectors, including business, disability management, education, healthcare, insurance, and workers' compensation. By utilizing an artificial intelligence-powered platform, Starling Minds licenses its technology to insurance payers, healthcare providers, and employers in a business-to-business model. This approach aims to alleviate the chronic shortage of affordable mental health professionals by offering effective support for employees, facilitating their return to work, and promoting overall workplace productivity and mental well-being.
CryoLogistics
Seed Round in 2018
CryoLogistics Refrigeration Technologies, based in British Columbia, specializes in clean-tech cold chain equipment manufacturing. The company has developed a modular, liquid-cooled shipping container that utilizes carbon dioxide for refrigeration. This innovative container is designed to transport palletized loads of high-value, temperature-sensitive food and pharmaceuticals efficiently through the global supply chain. By offering rapid and reliable cooling power, CryoLogistics enables shippers to reduce transportation costs, improve delivery speed, and expand their customer base, all while minimizing total emissions compared to traditional refrigeration systems.
Wantering
Seed Round in 2012
Wantering is an online fashion discovery platform based in Vancouver, Canada, that helps users find and purchase clothing from a curated selection of boutiques, flash sales sites, and major retailers. The platform consolidates fashion blogs and social networks, creating a comprehensive digest of interesting fashion products available online. As of November 2015, Wantering operates as a subsidiary of Clique Media, Inc.
LightIntegra Technology
Seed Round in 2009
LightIntegra Technology Inc. is a medical diagnostics company based in Vancouver, Canada, founded in 2009. It specializes in in-vitro diagnostic tests aimed at improving platelet transfusion outcomes. Its primary product, ThromboLUX, provides both qualitative and quantitative analysis of microparticle content in platelet samples, which is essential for determining the suitability of platelet units for therapeutic or prophylactic use. The ThromboLUX test kit is complemented by a control kit and ThromboSight software, which assists healthcare professionals in analyzing test results. The company's innovation stems from research conducted in collaboration with Canadian Blood Services, led by Dr. Elisabeth Maurer, who utilized advancements in dynamic light scattering and laser technology to develop a rapid and effective diagnostic solution for assessing platelet quality and function.
General Fusion
Seed Round in 2007
General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.
Bionic Power
Seed Round in 2007
Bionic Power is a privately-held technology company based in Vancouver, British Columbia, that specializes in wearable technology for battery charging. The company is primarily focused on developing its PowerWalk® Kinetic Energy Harvester for the U.S. military. In addition to this, Bionic Power creates lower-body smart orthoses aimed at improving personal mobility and enhancing walking abilities. These orthoses are designed to improve knee motion during walking, rebuild weakened muscles, and enhance overall mobility, ultimately increasing walking efficiency and reducing fatigue for users.
MailChannels
Seed Round in 2007
MailChannels Corporation, founded in 2004 and based in Vancouver, Canada, specializes in email filtering and delivery solutions that address issues related to IP blacklisting and spam. The company offers two primary services: MailChannels Cloud, an email relay service that enhances email reputation and delivery reliability by identifying spammers within a network, and MailChannels Dedicated, a carrier-grade software designed to block spam from networks to the Internet. Its services are primarily utilized by shared hosting, dedicated hosting, VPS hosting, cloud hosting, and Internet service providers, aiming to improve customer satisfaction and secure outbound mail traffic. Notable clients include Enom, Arvixe, SendGrid, SherWeb, and Hostwinds.
Zymeworks
Seed Round in 2005
Zymeworks Inc. is a clinical-stage biopharmaceutical company based in Vancouver, Canada, focused on the discovery, development, and commercialization of innovative biotherapeutics for cancer treatment. The company's lead candidates include ZW25, a bispecific antibody undergoing Phase I and II clinical trials for various tumors, including biliary tract and gastroesophageal adenocarcinomas, and ZW49, a bispecific antibody-drug conjugate in Phase I trials for advanced HER2-expressing cancers. Zymeworks employs a computational biotechnology approach, utilizing proprietary molecular modeling and simulation technologies to optimize therapeutic antibodies and other protein-based therapeutics. The company has established strategic partnerships with notable organizations such as Merck, Eli Lilly, and Bristol-Myers Squibb, as well as collaborations aimed at advancing antibody discovery and development. Founded in 2003, Zymeworks is dedicated to addressing unmet medical needs through its advanced therapeutic platforms and integrated drug development capabilities.
Aprio Inc. develops a board management platform that simplifies governance for organizations of various sizes, including financial institutions, non-profits, and public companies. Founded in 2003 and based in Vancouver, Canada, Aprio's software facilitates board meetings by automating agenda creation and providing tools for administrators to manage directors and committees. The platform enhances communication and decision-making by enabling secure collaboration from any location, while also allowing organizations to track board activity through comprehensive reporting. Aprio is recognized for its commitment to delivering an exceptional customer experience and making governance more accessible and efficient.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.